Company page

Universal Ibogaine Inc

Universal Ibogaine Inc, trading under the ticker IBO, is a public company based in Canada with a market capitalization of approximately CAD 996,243. The company focuses on developing treatments utilizing ibogaine, a compound derived from the iboga plant, for addressing substance use disorders. Universal Ibogaine aims to advance its research and therapeutic applications in this emerging field.